Fig. 6

Expression profiling of major components involved in PD-1/PD-L1 inhibitory signal and CXCL13-CXCR5 axis in HCC and TNBC. As stratified by therapeutic strategies, differential expression levels of MYC, activated (phosphorylated) MYC, PD-1, PD-L1, CXCL13 and CXCR5 can be detected in (A) HCC and (B) TNBC tumor cells or stroma cells (TME). ^*, p < 0.05; ^**, p < 0.01; ^***, p < 0.005; ^****, p < 0.001